Publications

• Insurance Industry Corporate Governance Newsletter
  07 November 2023
  Eric Dinallo
  ,
  Avi Gesser
  ,
  Nicholas F. Potter
  ,
  Johanna N. Skrzypczyk
  ,
  Michael Pizzi
  ,
  Ned Terrace
• Insurance Industry Corporate Governance Newsletter
  August 2023
  Charu A. Chandrasekhar
  ,
  Eric Dinallo
  ,
  Avi Gesser
  ,
  Benjamin R. Pedersen
  ,
  Nicholas F. Potter
• 2023 Proxy Season in Review
  1 August 2023
  Gregory V. Gooding
  ,
  Eric T. Juergens
  ,
  Matthew E. Kaplan
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Marisa Demko
• 2023 Private Equity Midyear Outlook
  27 July 2023
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Dominic Blaxill
  ,
  Joe Binder
  ,
  Ezra Borut
  ,
  Geoffrey P. Burgess
  ,
  Andrew J. Ceresney
  ,
  Jeffrey P. Cunard
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Andrew Ford
  ,
  Andrew J. Gershon
  ,
  Mark P. Goodman
  ,
  Jyotin Hamid
  ,
  Ted Hassi
  ,
  Morgan J. Hayes
  ,
  Emily F. Huang
  ,
  Peter J. Irwin
  ,
  Eric T. Juergens
  ,
  Robert B. Kaplan
  ,
  Rafael Kariyev
  ,
  Meir D. Katz
  ,
  M. Natasha Labovitz
  ,
  Maurizio Levi-Minzi
  ,
  Andrew M. Levine
  ,
  Sidney P. Levinson
  ,
  Jonathan F. Lewis
  ,
  Timothy McIver
  ,
  Franklin L. Mitchell
  ,
  Maura Kathleen Monaghan
  ,
  Edwin Northover
  ,
  Brett M. Novick
  ,
  Marc Ponchione
  ,
  Julie M. Riewe
  ,
  Shannon Rose Selden
  ,
  Steven J. Slutzky
  ,
  Thomas Smith
  ,
  Kristin A. Snyder
  ,
  J. Michael Snypes, Jr.
  ,
  Patrick Taylor
  ,
  Ramya S. Tiller
  ,
  Patricia Volhard
  ,
  Richard Ward
  ,
  Erica S. Weisgerber
  ,
  Alison E. Buckley-Serfass
  ,
  Brett Adam Bush
  ,
  Zhiyan Cao
  ,
  Robert T. Dura
  ,
  Stuart Hammer
  ,
  Megan McGuiggan
  ,
  Sheena Paul
  ,
  Tricia Bozyk Sherno
  ,
  Ulysses Smith
  ,
  Jacob W. Stahl
  ,
  Sergio Torres
  ,
  Jennifer Wheater
  ,
  Elie J. Worenklein
  ,
  Adam Aukland-Peck
  ,
  Colleen B. Bernaiche
  ,
  Charles Cartiglia
  ,
  Paul Eastham
  ,
  Jay E. Evans
  ,
  Sara Ewad
  ,
  Christopher Gossage
  ,
  Camila Isern
  ,
  Yiran Ji
  ,
  Maryam Kanna
  ,
  Rekha Korlipara
  ,
  Adriana Kranjac
  ,
  Samuel D. Krawiecz
  ,
  Merryl Lawry-White
  ,
  Megan MacDonald
  ,
  Harshil Mehta
  ,
  Gianni Pizzitola
  ,
  Stanley G. Seckler
  ,
  Sheng Shao
  ,
  Massy Vainshtein
  ,
  Kimberly Anker
• Debevoise & Plimpton Special Committee Report Issue 6
  July 2023
  Andrew L. Bab
  ,
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Elliot Greenfield
  ,
  Emily F. Huang
  ,
  Jonathan E. Levitsky
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Shannon Rose Selden
  ,
  Jonathan R. Tuttle
  ,
  Caitlin Gibson
  ,
  Erik J. Andrén
  ,
  Matthew Ryan
• Delaware Clarifies Standard for Reviewing Board Interference with Election Contests
  11 July 2023
  Gregory V. Gooding
  ,
  Maeve O'Connor
  ,
  William D. Regner
• Insurance Industry Corporate Governance Newsletter
  28 June 2023
  Eric Dinallo
  ,
  Nicholas F. Potter
  ,
  Ulysses Smith
  ,
  Brita M. Siepker
• ILPA Publishes New Guidance on Continuation Funds
  2 June 2023
  Andrew M. Ahern
  ,
  Gavin Anderson
  ,
  Katherine Ashton
  ,
  Ezra Borut
  ,
  Jane Engelhardt
  ,
  John W. Rife III
  ,
  Kevin M. Schmidt
  ,
  Shawn Xiao Yang
  ,
  Andrew J. Gershon
  ,
  Anne-Lise Quach
  ,
  Guang Yang
• FDA Guidance Offers Additional Clarity for Decentralized Clinical Trials
  30 May 2023
  Andrew L. Bab
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
  ,
  Michael L. Cederblom
• Carve-Out Deals Today: Overcoming Complexity and Unlocking Value
  May 2023
  Michael Bolotin
  ,
  Jennifer L. Chu
  ,
  Meir D. Katz
  ,
  Henry Lebowitz
  ,
  Kevin M. Schmidt
  ,
  Scott B. Selinger
  ,
  Caroline P. Geiger
  ,
  Keith J. Slattery
  ,
  David Deutsch
  ,
  Tigist Kassahun
  ,
  Dominique Trudelle
• Private Equity Report Spring 2023, Vol 23, No 1
  May 2023
  Michael Bolotin
  ,
  Jennifer L. Chu
  ,
  Avi Gesser
  ,
  Meir D. Katz
  ,
  Henry Lebowitz
  ,
  Marc Ponchione
  ,
  Kevin M. Schmidt
  ,
  Shannon Rose Selden
  ,
  Scott B. Selinger
  ,
  Kristin A. Snyder
  ,
  Matthew J. Sorensen
  ,
  Charu A. Chandrasekhar
  ,
  Matt Kelly
  ,
  Caroline P. Geiger
  ,
  Sheena Paul
  ,
  Keith J. Slattery
  ,
  Suchita Mandavilli Brundage
  ,
  David Deutsch
  ,
  Tigist Kassahun
  ,
  Melissa Muse
  ,
  Dominique Trudelle
  ,
  Massy Vainshtein
• Artificial Intelligence and the Life Sciences Industry: FDA and FTC Regulatory Update
  16 May 2023
  Andrew L. Bab
  ,
  Avi Gesser
  ,
  Paul D. Rubin
  ,
  Melissa Runsten
• Legal Dispute Surrounding Abortion Pill Has Significant Implications for Broader Healthcare Industry
  9 May 2023
  Andrew L. Bab
  ,
  Maura Kathleen Monaghan
  ,
  Paul D. Rubin
  ,
  Shannon Rose Selden
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
  ,
  Prakriti Luthra
  ,
  Melissa Runsten
  ,
  Charlotte Blatt
• Insurance Industry Corporate Governance Newsletter
  27 April 2023
  Eric Dinallo
  ,
  Susan Reagan Gittes
  ,
  Nicholas F. Potter
• Corporate Governance: Super Voting Preferred Stock
  11 April 2023
  Eric T. Juergens
  ,
  Maeve O'Connor
  ,
  Benjamin R. Pedersen
  ,
  William D. Regner
  ,
  Thomas Rose
• The Mindbody Problem
  17 March 2023
  Gregory V. Gooding
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Caitlin Gibson
• New York Seeks Review and Approval Authority over Certain Healthcare Transactions
  7 March 2023
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Michael L. Cederblom
• Proceed with Caution: Online Tracking Technologies Pose HIPAA Compliance Risks
  2 March 2023
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Michael L. Cederblom
• Considerations for a Possible Debt Ceiling Standoff
  2 February 2023
  Jonathan Adler
  ,
  Jennifer L. Chu
  ,
  Erin Cleary
  ,
  Eric T. Juergens
  ,
  Matthew E. Kaplan
  ,
  Jeffrey J. Rosen
  ,
  Scott B. Selinger
• Debevoise & Plimpton Special Committee Report Issue 5
  January 2023
  Andrew L. Bab
  ,
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Elliot Greenfield
  ,
  Emily F. Huang
  ,
  Jonathan E. Levitsky
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Shannon Rose Selden
  ,
  Jonathan R. Tuttle
  ,
  Caitlin Gibson
  ,
  Erik J. Andrén
  ,
  Matthew Ryan
• Delaware Court of Chancery Allows Caremark Claim
  26 January 2023
  Susan Reagan Gittes
  ,
  Gregory V. Gooding
  ,
  Elliot Greenfield
  ,
  Maeve O'Connor
  ,
  William D. Regner
• Private Equity Report: 2023 Outlook
  January 2023
  Catherine Amirfar
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Jason Auerbach
  ,
  Dominic Blaxill
  ,
  Ezra Borut
  ,
  Kara Brockmeyer
  ,
  Geoffrey P. Burgess
  ,
  Lawrence K. Cagney
  ,
  Andrew J. Ceresney
  ,
  Jennifer L. Chu
  ,
  Alexander R. Cochran
  ,
  Eric Dinallo
  ,
  Christopher Dortschy
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Jyotin Hamid
  ,
  Ted Hassi
  ,
  Morgan J. Hayes
  ,
  Gareth Hughes
  ,
  Peter J. Irwin
  ,
  Mark Johnson
  ,
  Eric T. Juergens
  ,
  Rafael Kariyev
  ,
  Meir D. Katz
  ,
  Satish M. Kini
  ,
  M. Natasha Labovitz
  ,
  Henry Lebowitz
  ,
  Maurizio Levi-Minzi
  ,
  Andrew M. Levine
  ,
  Sidney P. Levinson
  ,
  Jonathan F. Lewis
  ,
  Marilyn A. Lion
  ,
  Timothy McIver
  ,
  John (Jay) Neukom
  ,
  Benjamin R. Pedersen
  ,
  Marc Ponchione
  ,
  Nicholas F. Potter
  ,
  Ryan T. Rafferty
  ,
  Julie M. Riewe
  ,
  Samantha J. Rowe
  ,
  Paul D. Rubin
  ,
  Scott B. Selinger
  ,
  Jane Shvets
  ,
  Steven J. Slutzky
  ,
  Patricia Volhard
  ,
  Erica S. Weisgerber
  ,
  Barbara N. Barath
  ,
  Alison E. Buckley-Serfass
  ,
  Zhiyan Cao
  ,
  Robert T. Dura
  ,
  Robert M. Fettman
  ,
  Samuel Fung
  ,
  Caroline P. Geiger
  ,
  Andrew J. Gershon
  ,
  Jin-Hyuk Jang
  ,
  Stuart Hammer
  ,
  Kim T. Le
  ,
  Michael P. McGuigan
  ,
  Sheena Paul
  ,
  Tricia Bozyk Sherno
  ,
  Jennifer Wheater
  ,
  John Young
  ,
  Jeffrey P. Cunard
  ,
  Ulysses Smith
  ,
  Jennifer R. Cestaro
  ,
  Paul Eastham
  ,
  Isabel Espinosa de los Reyes
  ,
  Jay E. Evans
  ,
  Christopher Gossage
  ,
  Berk Guler
  ,
  Yiran Ji
  ,
  Samuel D. Krawiecz
  ,
  Chaim Lapp
  ,
  Stacy S. Lee
  ,
  Lucy Litt
  ,
  Megan MacDonald
  ,
  Emily MacKay
  ,
  Alma M. Mozetič
  ,
  Ezra Newman
  ,
  Melissa Runsten
  ,
  Sergio Torres
  ,
  George Tan
  ,
  Tiffany Wu
  ,
  Emma Macfarlane
  ,
  Sarah Min
  ,
  Matthew Stromecki
  ,
  Massy Vainshtein
• Another SPAC Merger Case Draws Entire Fairness Review
  20 January 2023
  Christopher Anthony
  ,
  Michael Diz
  ,
  Spencer K. Gilbert
  ,
  Gregory V. Gooding
  ,
  William D. Regner
  ,
  Shannon Rose Selden
• Potential Bylaw Amendments in Light of Universal Proxy Rules
  9 January 2023
  Eric T. Juergens
  ,
  Matthew E. Kaplan
  ,
  Benjamin R. Pedersen
  ,
  William D. Regner
  ,
  Steven J. Slutzky
  ,
  Sarah R. Jacobson
• Top 15 Healthcare and Life Sciences Issues to Watch in 2023
  9 January 2023
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Elie J. Worenklein
  ,
  Samuel J. Allaman
  ,
  Adam Aukland-Peck
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
  ,
  Adam C. Saunders
  ,
  Adrian St. Francis
  ,
  Emily G. Dennan
  ,
  Michael L. Cederblom
  ,
  Micah A. Rubin
• Frequently Asked Questions: Universal Proxy and Contested Director Elections
  14 December 2022
  Eric T. Juergens
  ,
  Matthew E. Kaplan
  ,
  Benjamin R. Pedersen
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Steven J. Slutzky
  ,
  Sarah R. Jacobson
  ,
  Chika Ojukwu
• Shareholder Proposals under Rule 14a-8: Practical Guidance for Proxy Season
  14 December 2022
  Eric T. Juergens
  ,
  Nicholas P. Pellicani
  ,
  William D. Regner
  ,
  John Jacob
  ,
  Austin Poon
  ,
  Ashley Yoon
• FTX Collapse Causes SEC to Request Additional Crypto Asset Disclosures
  13 December 2022
  Andrew L. Bab
  ,
  Morgan J. Hayes
  ,
  Sidney P. Levinson
  ,
  Benjamin R. Pedersen
  ,
  Katherine Durnan Taylor
  ,
  Alison M. Hashmall
  ,
  Elie J. Worenklein
  ,
  Chris Gallucci
  ,
  Ezra Newman
  ,
  Jonathan Steinberg
• Avoiding Surprises in Brazilian M&A
  November 2022
  Maurizio Levi-Minzi
  ,
  Sergio Torres
• Implications of the Inflation Reduction Act for Investors in Life Sciences Companies
  November 2022
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Hannah R. Levine
  ,
  Michael L. Cederblom
• Structuring Options for Addressing the New 1% Excise Tax
  November 2022
  Andrew L. Bab
  ,
  Michael Bolotin
  ,
  Erin Cleary
  ,
  David N. Simpser
• Your Contract Can Only Be Amended in Writing? Not So Fast.
  November 2022
  Gregory V. Gooding
• Cautionary Tale from Delaware: Restrictive Covenants Binding Sellers Must Be Narrowly Tailored
  27 October 2022
  Andrew L. Bab
  ,
  Gregory V. Gooding
  ,
  Emily F. Huang
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Caitlin Gibson
• Dealmaking Implications of California’s New Healthcare Cost Monitoring Law
  19 August 2022
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Hannah R. Levine
• Debevoise & Plimpton Special Committee Report Issue 4
  August 2022
  Andrew L. Bab
  ,
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Elliot Greenfield
  ,
  Emily F. Huang
  ,
  Jonathan E. Levitsky
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Shannon Rose Selden
  ,
  Jonathan R. Tuttle
  ,
  Erik J. Andrén
• Recent SCOTUS Decisions Impacting Healthcare
  3 August 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
• 2022 Private Equity Midyear Review and Outlook
  1 August 2022
  Jonathan Adler
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Sally Bergmann Hardesty
  ,
  Dominic Blaxill
  ,
  Ezra Borut
  ,
  Geoffrey P. Burgess
  ,
  Jennifer L. Chu
  ,
  Christopher Dortschy
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Avi Gesser
  ,
  Jyotin Hamid
  ,
  Morgan J. Hayes
  ,
  Emily F. Huang
  ,
  Peter J. Irwin
  ,
  Satish M. Kini
  ,
  M. Natasha Labovitz
  ,
  Andrew M. Levine
  ,
  Sidney P. Levinson
  ,
  Marilyn A. Lion
  ,
  Peter J. Loughran
  ,
  Nicole Levin Mesard
  ,
  Brett M. Novick
  ,
  Marc Ponchione
  ,
  Ryan T. Rafferty
  ,
  Jeffrey E. Ross
  ,
  Scott B. Selinger
  ,
  Steven J. Slutzky
  ,
  Thomas Smith
  ,
  Ramya S. Tiller
  ,
  Patricia Volhard
  ,
  Richard Ward
  ,
  Jeffrey P. Cunard
  ,
  Tricia Bozyk Sherno
  ,
  Marshal L. Bozzo
  ,
  Zhiyan Cao
  ,
  Robert T. Dura
  ,
  Andrew J. Gershon
  ,
  Stuart Hammer
  ,
  Sheena Paul
  ,
  Jin-Hyuk Jang
  ,
  Jennifer Wheater
  ,
  John Young
  ,
  Ulysses Smith
  ,
  Jennifer R. Cestaro
  ,
  Thomas A. DeMarzo
  ,
  Paul Eastham
  ,
  Isabel Espinosa de los Reyes
  ,
  Michael C. Godbe
  ,
  Christopher Gossage
  ,
  Merryl Lawry-White
  ,
  Sheng Shao
  ,
  Rachel Tennell
  ,
  Malina Welman
  ,
  Matthew Mrozek
  ,
  Chika Ojukwu
  ,
  Yiran Ji
• FTC Sharpens Focus on Private Equity
  17 June 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Ted Hassi
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Leah Martin
  ,
  Adam C. Saunders
• California Poised to Grant Attorney General Broad Approval Authority over Healthcare Transactions
  16 June 2022
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Hannah R. Levine
• Navigating the Dynamic World of Antitrust Divestitures
  May 2022
  Andrew L. Bab
  ,
  Ted Hassi
• The Proposed SPAC Rules and Their Impact on Investment Banks
  27 April 2022
  Christopher Anthony
  ,
  Andrew L. Bab
  ,
  Gregory V. Gooding
  ,
  Morgan J. Hayes
  ,
  Peter J. Loughran
  ,
  William D. Regner
  ,
  Steven J. Slutzky
• SEC Proposes Major Rule Changes for SPACs
  18 April 2022
  Christopher Anthony
  ,
  Morgan J. Hayes
  ,
  Peter J. Loughran
  ,
  Marc Ponchione
  ,
  Zachary H. Saltzman
  ,
  Shannon Rose Selden
  ,
  Steven J. Slutzky
  ,
  Chika Ojukwu
• Texas Federal Judge Sides with Providers in “No Surprises Act” Ruling
  1 March 2022
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
  ,
  Adriana Kranjac
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
• Debevoise & Plimpton Special Committee Report Issue 3
  February 2022
  Andrew L. Bab
  ,
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Elliot Greenfield
  ,
  Emily F. Huang
  ,
  Jonathan E. Levitsky
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Shannon Rose Selden
  ,
  Jonathan R. Tuttle
• 2021/2022 Private Equity Year-End Review and Outlook
  January 2022
  Jonathan Adler
  ,
  Catherine Amirfar
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Andrew L. Bab
  ,
  Geoffrey P. Burgess
  ,
  Ezra Borut
  ,
  Andrew J. Ceresney
  ,
  Jennifer L. Chu
  ,
  Jeffrey P. Cunard
  ,
  Alexander R. Cochran
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Morgan J. Hayes
  ,
  Eric T. Juergens
  ,
  Maurizio Levi-Minzi
  ,
  Nicholas P. Pellicani
  ,
  Ryan T. Rafferty
  ,
  Julie M. Riewe
  ,
  Scott B. Selinger
  ,
  Marc Ponchione
  ,
  Thomas Smith
  ,
  Ramya S. Tiller
  ,
  Patricia Volhard
  ,
  Richard Ward
  ,
  Alisa A. Waxman
  ,
  Marshal L. Bozzo
  ,
  Christopher Dortschy
  ,
  Andrew J. Gershon
  ,
  Emily F. Huang
  ,
  Jennifer Wheater
  ,
  Dominic Blaxill
  ,
  Charles Cartiglia
  ,
  Robert T. Dura
  ,
  Matthew J. Sacco
  ,
  Sheng Shao
  ,
  Sergio Torres
  ,
  Charlotte A. Walkovik
  ,
  Paul Eastham
  ,
  Christopher Gossage
  ,
  Robert B. Kaplan
  ,
  Sheena Paul
  ,
  John Young
  ,
  Jin-Hyuk Jang
  ,
  Lukas Ott
  ,
  Andrew M. Levine
  ,
  Stuart Hammer
  ,
  Ulysses Smith
  ,
  Merryl Lawry-White
  ,
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Michael R. Roberts
  ,
  Peter J. Irwin
  ,
  Ina C. Popova
  ,
  Samantha J. Rowe
  ,
  M. Natasha Labovitz
  ,
  Sidney P. Levinson
  ,
  Paul D. Rubin
  ,
  Eric Dinallo
  ,
  Marilyn A. Lion
  ,
  Jacob W. Stahl
  ,
  Nicholas F. Potter
  ,
  Kim T. Le
  ,
  Adam Aukland-Peck
  ,
  Melissa Runsten
  ,
  Matthew Mrozek
  ,
  Michael C. Godbe
  ,
  Christel Y. Tham
  ,
  Lisa Wang Lachowicz
  ,
  Yiran Ji
• Delaware Court Holds de-SPAC Transaction Subject to Entire Fairness
  14 January 2022
  Christopher Anthony
  ,
  Gregory V. Gooding
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Zachary H. Saltzman
  ,
  Shannon Rose Selden
• What Happened at COP26? The Glasgow Climate Pact and Other Key Developments
  18 November 2021
  Catherine Amirfar
  ,
  Geoffrey P. Burgess
  ,
  Lord Goldsmith KC
  ,
  Andrew M. Levine
  ,
  William D. Regner
  ,
  Natalie L. Reid
  ,
  Samantha J. Rowe
  ,
  Jeffrey J. Rosen
  ,
  Patricia Volhard
  ,
  Bruce E. Yannett
  ,
  Ulysses Smith
  ,
  Floriane Lavaud
  ,
  Charlotte Bocage
  ,
  Merryl Lawry-White
  ,
  Romain Zamour
• Buyer Beware: The FTC’s Revived and Expanded Prior Approval Policy
  8 November 2021
  Ted Hassi
  ,
  Michael Schaper
  ,
  Kevin M. Schmidt
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• Debevoise & Plimpton Special Committee Report Issue 2
  September 2021
  Andrew L. Bab
  ,
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Elliot Greenfield
  ,
  Emily F. Huang
  ,
  Jonathan E. Levitsky
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Shannon Rose Selden
  ,
  Jonathan R. Tuttle
• 2021 Private Equity Midyear Review and Outlook
  22 July 2021
  Jonathan Adler
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Andrew L. Bab
  ,
  Megan K. Bannigan
  ,
  Sally Bergmann Hardesty
  ,
  David H. Bernstein
  ,
  Paul S. Bird
  ,
  Ezra Borut
  ,
  Geoffrey P. Burgess
  ,
  Jennifer L. Chu
  ,
  Matthew Dickman
  ,
  Christopher Dortschy
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Peter A. Furci
  ,
  Avi Gesser
  ,
  Jyotin Hamid
  ,
  Morgan J. Hayes
  ,
  Peter J. Irwin
  ,
  Meir D. Katz
  ,
  Rafael Kariyev
  ,
  M. Natasha Labovitz
  ,
  Maurizio Levi-Minzi
  ,
  Andrew M. Levine
  ,
  Sidney P. Levinson
  ,
  Jonathan F. Lewis
  ,
  Marc Ponchione
  ,
  Ryan T. Rafferty
  ,
  Paul D. Rubin
  ,
  Zachary H. Saltzman
  ,
  Kevin M. Schmidt
  ,
  Shannon Rose Selden
  ,
  Scott B. Selinger
  ,
  Steven J. Slutzky
  ,
  Ramya S. Tiller
  ,
  Richard Ward
  ,
  Alisa A. Waxman
  ,
  Patricia Volhard
  ,
  Franci J. Blassberg
  ,
  Jeffrey P. Cunard
  ,
  Andrew J. Gershon
  ,
  Stuart Hammer
  ,
  Jin-Hyuk Jang
  ,
  Kim T. Le
  ,
  Sheena Paul
  ,
  Tricia Bozyk Sherno
  ,
  Jacob W. Stahl
  ,
  Jennifer Wheater
  ,
  John Young
  ,
  Adam Aukland-Peck
  ,
  Dominic Blaxill
  ,
  Charles Cartiglia
  ,
  Robert T. Dura
  ,
  Paul Eastham
  ,
  Jay E. Evans
  ,
  Norma Angelica Lopez Campos
  ,
  David J. Hotelling
  ,
  Samuel D. Krawiecz
  ,
  Wen-Wei Lai
  ,
  Merryl Lawry-White
  ,
  Robert Maddox
  ,
  Sergio Torres
  ,
  Malina Welman
• Locked Boxes in U.S. Practice: An Underused Tool?
  May 2021
  Jennifer L. Chu
  ,
  Uri Herzberg
  ,
  Spencer K. Gilbert
• Private Equity Report Spring 2021, Vol 21, No 1
  May 2021
  Christopher Anthony
  ,
  Paul S. Bird
  ,
  E. Raman Bet-Mansour
  ,
  Geoffrey P. Burgess
  ,
  Jennifer L. Chu
  ,
  Alexander R. Cochran
  ,
  E. Drew Dutton
  ,
  Gregory V. Gooding
  ,
  David Grosgold
  ,
  Morgan J. Hayes
  ,
  Uri Herzberg
  ,
  Eric T. Juergens
  ,
  Robert B. Kaplan
  ,
  Marilyn A. Lion
  ,
  Edwin Northover
  ,
  Marc Ponchione
  ,
  Nicholas F. Potter
  ,
  Julie M. Riewe
  ,
  Samantha J. Rowe
  ,
  Kevin M. Schmidt
  ,
  James C. Scoville
  ,
  Shannon Rose Selden
  ,
  Scott B. Selinger
  ,
  Steven J. Slutzky
  ,
  Patricia Volhard
  ,
  Matthew Dickman
  ,
  Jin-Hyuk Jang
  ,
  Andrew G. Jamieson
  ,
  Benjamin Lyon
  ,
  Dr. Clare Swirski
  ,
  Norma Angelica Lopez Campos
  ,
  Adrian St. Francis
  ,
  Laurence Hanesworth
  ,
  Spencer K. Gilbert
  ,
  Matthew B. Parelman
  ,
  Brett M. Novick
• Introducing the Debevoise & Plimpton Special Committee Report
  7 April 2021
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Jonathan E. Levitsky
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Jonathan R. Tuttle
  ,
  Emily F. Huang
• The American Rescue Plan Act of 2021: Implications for Healthcare and Life Sciences Companies
  12 March 2021
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
  ,
  Benjamin Leb
• Proposed Elimination of Medicaid Rebate Cap Could Negatively Impact Innovator Pharmaceutical Industry
  11 February 2021
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• Biden Takes Aim at Trump Administration Healthcare Policies
  2 February 2021
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• Governance Round-Up Issue 12
  1 February 2021
  Matthew E. Kaplan
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
  ,
  Steven J. Slutzky
  ,
  Joshua M. Samit
  ,
  Sarah R. Jacobson
  ,
  Laurah J. Samuels
• 2020/2021 Private Equity Year End Review and Outlook
  7 January 2021
  Jonathan Adler
  ,
  William D. Regner
  ,
  John W. Rife III
  ,
  Alisa A. Waxman
  ,
  Jennifer R. Cestaro
  ,
  Katherine Ashton
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Thomas Smith
  ,
  Ramya S. Tiller
  ,
  Christopher Anthony
  ,
  Kevin M. Schmidt
  ,
  Maurizio Levi-Minzi
  ,
  Geoffrey P. Burgess
  ,
  Dominic Blaxill
  ,
  Wen-Wei Lai
  ,
  Jyotin Hamid
  ,
  Morgan J. Hayes
  ,
  Steven J. Slutzky
  ,
  Richard Ward
  ,
  Jennifer Wheater
  ,
  Paul Eastham
  ,
  Peter A. Furci
  ,
  Rafael Kariyev
  ,
  Jay E. Evans
  ,
  Samuel D. Krawiecz
  ,
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Jyotin Hamid
  ,
  Meir D. Katz
  ,
  Jonathan F. Lewis
  ,
  Tricia Bozyk Sherno
  ,
  Ezra Borut
  ,
  Jeffrey P. Cunard
  ,
  Marc Ponchione
  ,
  Kenneth J. Berman
  ,
  Norma Angelica Lopez Campos
  ,
  Patricia Volhard
  ,
  Christopher Dortschy
  ,
  Jin-Hyuk Jang
  ,
  John Young
  ,
  Andrew J. Ceresney
  ,
  Robert B. Kaplan
  ,
  Julie M. Riewe
  ,
  Merryl Lawry-White
  ,
  Sally Bergmann Hardesty
  ,
  Scott B. Selinger
  ,
  Stuart Hammer
  ,
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Jim Pastore
  ,
  Megan K. Bannigan
  ,
  David H. Bernstein
  ,
  M. Natasha Labovitz
  ,
  Sidney P. Levinson
  ,
  Peter J. Irwin
  ,
  Malina Welman
  ,
  Paul S. Bird
• Consolidated Appropriations Act: Implications for Healthcare and Life Sciences Companies
  30 December 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kristin D. Kiehn
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• Hasta Mañana: What Will Tomorrow Bring for Latin American Private Equity?
  December 2020
  Maurizio Levi-Minzi
  ,
  Peter A. Furci
  ,
  Andrew M. Levine
  ,
  Sergio Torres
• Private Equity Report Fall 2020, Vol 20, No 3
  December 2020
  Andrew M. Ahern
  ,
  Gavin Anderson
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Sally Bergmann Hardesty
  ,
  Paul S. Bird
  ,
  Franci J. Blassberg
  ,
  Ezra Borut
  ,
  Jennifer L. Chu
  ,
  Erin Cleary
  ,
  Peter A. Furci
  ,
  Maurizio Levi-Minzi
  ,
  Andrew M. Levine
  ,
  John W. Rife III
  ,
  Rebecca F. Silberstein
  ,
  Kevin M. Schmidt
  ,
  Steven J. Slutzky
  ,
  Rafael Kariyev
  ,
  Patricia Volhard
  ,
  Jin-Hyuk Jang
  ,
  John Young
  ,
  Marisa Demko
  ,
  Jay E. Evans
  ,
  Samuel D. Krawiecz
  ,
  Sergio Torres
  ,
  Wen-Wei Lai
  ,
  Tiffany Wu
  ,
  Shawn Xiao Yang
• SPACs Could Become Formidable Bidders in the M&A Market
  December 2020
  Christopher Anthony
  ,
  Kevin M. Schmidt
  ,
  Steven J. Slutzky
  ,
  Marisa Demko
• The Trump Administration’s Final Drug Pricing Hurrah—Will It Last?
  24 November 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• COVID-19 Vaccines: FDA Regulatory Timeline and Next Steps Prior to Widespread Distribution
  20 November 2020
  Paul D. Rubin
  ,
  Melissa Runsten
  ,
  Kevin Rinker
  ,
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Jennifer L. Chu
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• The Potential Impact of a Biden Administration on Life Sciences, Healthcare, and Consumer Product Companies and Investors
  2 November 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Maura Kathleen Monaghan
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• SEC Eases Auditor Independence Requirements
  23 October 2020
  Kara Brockmeyer
  ,
  Jennifer L. Chu
  ,
  Morgan J. Hayes
  ,
  Arian M. June
  ,
  Marc Ponchione
  ,
  Paul M. Rodel
  ,
  Jonathan Steinberg
• New York Law Journal: SPACs Could Become Formidable Bidders in the M&A Market
  16 October 2020
  New York Law Journal
  Christopher Anthony
  ,
  Kevin M. Schmidt
  ,
  Steven J. Slutzky
  ,
  Marisa Demko
• Regulation for Digital Platforms: Lessons from the Banking Industry
  9 October 2020
  Michael Diz
  ,
  David Sarratt
• Third Circuit Strikes Another Blow Against the FTC’s Preferred Enforcement Power, Setting the Stage for a Supreme Court Showdown
  5 October 2020
  Andrew L. Bab
  ,
  David H. Bernstein
  ,
  Ted Hassi
  ,
  Paul D. Rubin
  ,
  Leah Martin
  ,
  Melissa Runsten
• Trump’s Newest Drug Pricing Executive Order: Still Much More Bark than Bite
  16 September 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• HHS Announces Additional CARES Act Funding for Qualifying Providers
  4 August 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• 2020 Private Equity Midyear Review and Outlook
  31 July 2020
  Jonathan Adler
  ,
  Andrew M. Ahern
  ,
  Christopher Anthony
  ,
  Megan K. Bannigan
  ,
  David H. Bernstein
  ,
  Kenneth J. Berman
  ,
  Paul S. Bird
  ,
  Ezra Borut
  ,
  Geoffrey P. Burgess
  ,
  Jennifer R. Cestaro
  ,
  Jennifer L. Chu
  ,
  Andrew J. Ceresney
  ,
  Jeffrey P. Cunard
  ,
  Peter A. Furci
  ,
  Morgan J. Hayes
  ,
  Peter J. Irwin
  ,
  Robert B. Kaplan
  ,
  Rafael Kariyev
  ,
  M. Natasha Labovitz
  ,
  Andrew M. Levine
  ,
  Sidney P. Levinson
  ,
  Nicole Levin Mesard
  ,
  Marc Ponchione
  ,
  Julie M. Riewe
  ,
  Edward M. Rishty
  ,
  Kevin M. Schmidt
  ,
  Shannon Rose Selden
  ,
  Scott B. Selinger
  ,
  Steven J. Slutzky
  ,
  Thomas Smith
  ,
  Ramya S. Tiller
  ,
  Patricia Volhard
  ,
  Richard Ward
  ,
  Alisa A. Waxman
  ,
  Michael P. McGuigan
  ,
  Samuel D. Krawiecz
  ,
  Stuart Hammer
  ,
  Dominic Blaxill
  ,
  Christopher Dortschy
  ,
  Paul Eastham
  ,
  Jin-Hyuk Jang
  ,
  Jennifer Wheater
  ,
  John Young
  ,
  Almas Daud
  ,
  Paul Eastham
  ,
  Jay E. Evans
  ,
  Norma Angelica Lopez Campos
  ,
  Samuel D. Krawiecz
  ,
  Wen-Wei Lai
  ,
  Merryl Lawry-White
• Trump’s New Drug Pricing Executive Orders: Much More Bark Than Bite
  29 July 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
• Bill Ackman and Pershing Square Launch Largest SPAC To Date: A Harbinger of Things to Come?
  24 July 2020
  Christopher Anthony
  ,
  Steven J. Slutzky
• Back to Work: Protect Directors Too
  19 June 2020
  Harvard Law School Forum on Corporate Governance
  William D. Regner
  ,
  Jeffrey J. Rosen
• COVID-19-Related Changes to Foreign Direct Investment Rules Pose Unique Challenges to Secondaries Market
  11 June 2020
  Gavin Anderson
  ,
  Katherine Ashton
  ,
  Ezra Borut
  ,
  Geoffrey P. Burgess
  ,
  John W. Rife III
  ,
  Jake Grandison
• Sponsor Purchases of Portfolio Company Debt: Key Considerations in an Uncertain Environment
  14 May 2020
  Jonathan Adler
  ,
  Lorna Bowen
  ,
  Peter A. Furci
  ,
  Sidney P. Levinson
  ,
  Peter J. Loughran
  ,
  Jeffrey E. Ross
  ,
  Kevin M. Schmidt
  ,
  Scott B. Selinger
  ,
  Steven J. Slutzky
  ,
  Nicholas P. Pellicani
  ,
  Ryan T. Rafferty
  ,
  Julie Stem
• HHS Issues Additional Guidance on Qualifications for CARES Act Funding
  8 May 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• CLS Blue Sky Blog: Debevoise Discusses Private Equity Options in Face of Liquidity Crunch
  6 May 2020
  CLS Blue Sky Blog
  Andrew M. Ahern
  ,
  Gavin Anderson
  ,
  Katherine Ashton
  ,
  Ezra Borut
• Overview of the Main Street Lending Programs
  1 May 2020
  Michael Diz
  ,
  Jeffrey E. Ross
  ,
  Kevin M. Schmidt
  ,
  Zahra J. Khosrovi Sowder
• Appropriations for Healthcare Providers Related to COVID-19
  30 April 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• New Appropriation for Healthcare Providers
  24 April 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• HHS Announces Additional Funding for Healthcare Providers Impacted by COVID-19
  23 April 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• Sponsor Backed PIPEs: COVID-19 and the Race for Liquidity
  22 April 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Gary M. Friedman
  ,
  Gregory V. Gooding
  ,
  Uri Herzberg
  ,
  Jonathan E. Levitsky
  ,
  Sunil William Savkar
  ,
  Kevin M. Schmidt
  ,
  Shannon Rose Selden
  ,
  Katherine Durnan Taylor
  ,
  Steven J. Slutzky
• Summary of the U.S. Treasury and Federal Reserve Programs and the Paycheck Protection Program
  21 April 2020
  Matthew E. Kaplan
  ,
  Rafael Kariyev
  ,
  Satish M. Kini
  ,
  Gregory J. Lyons
  ,
  Nicole Levin Mesard
  ,
  Jeff Robins
  ,
  Jeffrey E. Ross
  ,
  Kevin M. Schmidt
  ,
  Steven J. Slutzky
  ,
  Alison M. Hashmall
  ,
  Chen Xu
• HHS Distributing $30 Billion in Grants to Medicare Providers
  10 April 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• NYSE Provides Temporary Relief from Certain Shareholder Approval Rules
  10 April 2020
  Jennifer L. Chu
  ,
  Gregory V. Gooding
  ,
  Morgan J. Hayes
  ,
  Eric T. Juergens
  ,
  Matthew E. Kaplan
  ,
  Peter J. Loughran
  ,
  Paul M. Rodel
  ,
  Steven J. Slutzky
• CMS Announces Intent to Provide $30 Billion to Medicare Providers
  9 April 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• Rethinking Poison Pills, Again
  9 April 2020
  Andrew L. Bab
  ,
  Gregory V. Gooding
  ,
  William D. Regner
  ,
  Sergio Torres
• Update Regarding Public Health and Social Services Emergency Fund
  6 April 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
• Projecting Performance in the Age of COVID-19
  3 April 2020
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Matthew E. Kaplan
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
• COVID-19 and Private Equity: The Impact of Financing Disruptions on Private Equity Portfolio Companies and Funds
  31 March 2020
  Jonathan Adler
  ,
  Jeffrey E. Ross
  ,
  Kevin M. Schmidt
  ,
  Scott B. Selinger
  ,
  Rebecca F. Silberstein
  ,
  Thomas Smith
• Present Tense: Allocating the Evolving Risk of COVID-19 in M&A Transactions
  30 March 2020
  Jennifer L. Chu
  ,
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  William D. Regner
  ,
  Kevin Rinker
  ,
  Jeffrey J. Rosen
• The Federal Government Throws a Lifeline to Medicare Providers and Suppliers
  30 March 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• CARES Act: Implications for Healthcare and Life Science Companies and Investors
  27 March 2020
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
• Delaware Supreme Court Upholds Federal-Forum Provisions for Securities Act Claims
  20 March 2020
  Matthew E. Kaplan
  ,
  Peter J. Loughran
  ,
  Maeve O'Connor
  ,
  William D. Regner
  ,
  Jonathan R. Tuttle
  ,
  Elliot Greenfield
• Preferred Equity Redemption Rights: “The Bitter and the Sweet”
  November 2021
  Gregory V. Gooding
  ,
  Uri Herzberg
  ,
  Kevin M. Schmidt
  ,
  Katherine Durnan Taylor
• SPACs: Key Regulatory Considerations for Private Equity Sponsors
  May 2021
  Christopher Anthony
  ,
  Morgan J. Hayes
  ,
  Robert B. Kaplan
  ,
  Marc Ponchione
  ,
  Julie M. Riewe
  ,
  Shannon Rose Selden
  ,
  Steven J. Slutzky
  ,
  Norma Angelica Lopez Campos
  ,
  Adrian St. Francis